Dosar de subiect

Altele

Eli Lilly to Acquire Centessa Therapeutics for $7.8 Billion

Primul articol: 31 mar. 2026, 17:24 | Ultima actualizare: 31 mar. 2026, 17:24 | 1 sursa | 1 articol
#elililly#centessa#pharma#acquisition

Mai multe surse. Mai putina manipulare.

Analiza editoriala

Bazat pe 1 sursa, 1 articol

Eli Lilly has announced its plan to acquire Centessa Therapeutics for $7.8 billion, a move that will significantly expand its drug development pipeline. Centessa, a pharmaceutical company focused on discovering and developing novel treatments for various diseases, offers Eli Lilly a portfolio of promising drug candidates in areas such as oncology and immunology. This acquisition underscores Eli Lilly's commitment to investing in innovative research and development to address unmet medical needs.

Articole despre acest subiect

Why Eli Lilly Is Buying Centessa for $7.8 Billion Foto: Bloomberg
Bloomberg English 31 mar. 2026, 17:24 (acum 3 ore)

Why Eli Lilly Is Buying Centessa for $7.8 Billion

Bloomberg Intelligence's Sam Fazeli discusses Eli Lilly's $7.8 billion acquisition of Centessa, marking the company's entry into the sleep disorder drug market. He speaks on "Bloomberg Open Interest." (Source: Bloomberg)

Citeste pe Bloomberg →